{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:49:58Z","timestamp":1792622998631,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00198-022-06470-3","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T04:03:04Z","timestamp":1656129784000},"page":"2177-2184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study"],"prefix":"10.1007","volume":"33","author":[{"given":"Tobias","family":"Rupp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"von Vopelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Strahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Oheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Barvencik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rolvien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"key":"6470_CR1","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1136\/annrheumdis-2013-204680","volume":"73","author":"E Smith","year":"2014","unstructured":"Smith E, Hoy DG, Cross M, Vos T, Naghavi M, Buchbinder R, Woolf AD, March L (2014) The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 73:1462\u20131469","journal-title":"Ann Rheum Dis"},{"key":"6470_CR2","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/annrheumdis-2013-204320","volume":"73","author":"L Sanchez-Riera","year":"2014","unstructured":"Sanchez-Riera L, Carnahan E, Vos T, Veerman L, Norman R, Lim SS, Hoy D, Smith E, Wilson N, Nolla JM, Chen JS, Macara M, Kamalaraj N, Li Y, Kok C, Santos-Hernandez C, March L (2014) The global burden attributable to low bone mineral density. Ann Rheum Dis 73:1635\u20131645","journal-title":"Ann Rheum Dis"},{"key":"6470_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/2049-3258-72-45","volume":"72","author":"C Beaudart","year":"2014","unstructured":"Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72:45","journal-title":"Arch Public Health"},{"key":"6470_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00223-015-9956-x","volume":"96","author":"CM Girgis","year":"2015","unstructured":"Girgis CM (2015) Integrated therapies for osteoporosis and sarcopenia: from signaling pathways to clinical trials. Calcif Tissue Int 96:243\u2013255","journal-title":"Calcif Tissue Int"},{"key":"6470_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jocd.2009.06.004","volume":"12","author":"N Binkley","year":"2009","unstructured":"Binkley N, Buehring B (2009) Beyond FRAX: it\u2019s time to consider \u201csarco-osteopenia.\u201d J Clin Densitom 12:413\u2013416","journal-title":"J Clin Densitom"},{"key":"6470_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/rheumatology\/keaa755","volume":"60","author":"MA Clynes","year":"2021","unstructured":"Clynes MA, Gregson CL, Bruyere O, Cooper C, Dennison EM (2021) Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology (Oxford) 60:529\u2013537","journal-title":"Rheumatology (Oxford)"},{"key":"6470_CR7","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00198-021-05963-x","volume":"32","author":"Z Teng","year":"2021","unstructured":"Teng Z, Zhu Y, Teng Y, Long Q, Hao Q, Yu X, Yang L, Lv Y, Liu J, Zeng Y, Lu S (2021) The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls. Osteoporos Int 32:2173\u20132183","journal-title":"Osteoporos Int"},{"key":"6470_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.bone.2010.12.025","volume":"48","author":"A Frisoli Jr","year":"2011","unstructured":"Frisoli A Jr, Chaves PH, Ingham SJM, Fried LP (2011) Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women\u2019s Health and Aging Study (WHAS) II. Bone 48:952\u2013957","journal-title":"Bone"},{"key":"6470_CR9","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"LG Raisz","year":"2005","unstructured":"Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318\u20133325","journal-title":"J Clin Invest"},{"key":"6470_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/jcsm.12567","volume":"11","author":"B Kirk","year":"2020","unstructured":"Kirk B, Zanker J, Duque G (2020) Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle 11:609\u2013618","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"6470_CR11","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nm.3917","volume":"21","author":"B Dankbar","year":"2015","unstructured":"Dankbar B, Fennen M, Brunert D, Hayer S, Frank S, Wehmeyer C, Beckmann D, Paruzel P, Bertrand J, Redlich K (2015) Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice. Nat Med 21:1085\u20131090","journal-title":"Nat Med"},{"key":"6470_CR12","doi-asserted-by":"publisher","first-page":"12157","DOI":"10.1073\/pnas.1516622112","volume":"112","author":"G Colaianni","year":"2015","unstructured":"Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, Lu P, Sartini L, Di Comite M, Mori G, Di Benedetto A, Brunetti G, Yuen T, Sun L, Reseland JE, Colucci S, New MI, Zaidi M, Cinti S, Grano M (2015) The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A 112:12157\u201312162","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6470_CR13","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.molmet.2016.07.002","volume":"5","author":"P Mera","year":"2016","unstructured":"Mera P, Laue K, Wei J, Berger JM, Karsenty G (2016) Osteocalcin is necessary and sufficient to maintain muscle mass in older mice. Mol Metab 5:1042\u20131047","journal-title":"Mol Metab"},{"key":"6470_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jbm4.10015","volume":"1","author":"J Huang","year":"2017","unstructured":"Huang J, Romero-Suarez S, Lara N, Mo C, Kaja S, Brotto L, Dallas SL, Johnson ML, Jahn K, Bonewald LF, Brotto M (2017) Crosstalk between MLO-Y4 osteocytes and C2C12 muscle cells is mediated by the Wnt\/beta-catenin pathway. JBMR plus 1:86\u2013100","journal-title":"JBMR plus"},{"key":"6470_CR15","doi-asserted-by":"publisher","first-page":"585644","DOI":"10.3389\/fcell.2020.585644","volume":"8","author":"C He","year":"2020","unstructured":"He C, He W, Hou J, Chen K, Huang M, Yang M, Luo X, Li C (2020) Bone and muscle crosstalk in aging. Front Cell Dev Biol 8:585644","journal-title":"Front Cell Dev Biol"},{"key":"6470_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, San Martin J, Dansey R (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11:401\u2013419","journal-title":"Nat Rev Drug Discov"},{"key":"6470_CR17","doi-asserted-by":"publisher","first-page":"C663","DOI":"10.1152\/ajpcell.00285.2015","volume":"310","author":"SS Dufresne","year":"2016","unstructured":"Dufresne SS, Dumont NA, Boulanger-Piette A, Fajardo VA, Gamu D, Kake-Guena S-A, David RO, Bouchard P, Lavergne \u00c9, Penninger JM (2016) Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles. Am J Physiol Cell Physiol 310:C663\u2013C672","journal-title":"Am J Physiol Cell Physiol"},{"key":"6470_CR18","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/hmg\/ddz124","volume":"28","author":"D Hamoudi","year":"2019","unstructured":"Hamoudi D, Marcadet L, Piette Boulanger A, Yagita H, Bouredji Z, Argaw A, Frenette J (2019) An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic mice. Hum Mol Genet 28:3101\u20133112","journal-title":"Hum Mol Genet"},{"key":"6470_CR19","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","volume":"129","author":"N Bonnet","year":"2019","unstructured":"Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S (2019) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 129:3214\u20133223","journal-title":"J Clin Invest"},{"key":"6470_CR20","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1111\/jgs.16165","volume":"67","author":"S Phu","year":"2019","unstructured":"Phu S, Bani Hassan E, Vogrin S, Kirk B, Duque G (2019) Effect of denosumab on falls, muscle strength, and function in community-dwelling older adults. J Am Geriatr Soc 67:2660\u20132661","journal-title":"J Am Geriatr Soc"},{"key":"6470_CR21","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1007\/s10067-021-05757-w","volume":"40","author":"YE Miedany","year":"2021","unstructured":"Miedany YE, Gaafary ME, Toth M, Hegazi MO, Aroussy NE, Hassan W, Almedany S, Nasr A, Bahlas S, Galal S (2021) Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia? Clin Rheumatol 40:4225\u20134232","journal-title":"Clin Rheumatol"},{"key":"6470_CR22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1495\u20131499","journal-title":"Int J Surg"},{"key":"6470_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11657-018-0490-0","volume":"13","author":"T Rupp","year":"2018","unstructured":"Rupp T, Butscheidt S, Jahn K, Simon MJ, Mussawy H, Oheim R, Barvencik F, Amling M, Rolvien T (2018) Low physical performance determined by chair rising test muscle mechanography is associated with prevalent fragility fractures. Arch Osteoporos 13:71","journal-title":"Arch Osteoporos"},{"key":"6470_CR24","doi-asserted-by":"publisher","first-page":"1809150","DOI":"10.1155\/2020\/1809150","volume":"2020","author":"A Rossini","year":"2020","unstructured":"Rossini A, Frigerio S, Dozio E, Trevisan R, Perseghin G, Corbetta S (2020) Effect of denosumab on glucose homeostasis in postmenopausal women with breast cancer treated with aromatase inhibitors: a pilot study. Int J Endocrinol 2020:1809150","journal-title":"Int J Endocrinol"},{"key":"6470_CR25","doi-asserted-by":"publisher","first-page":"612506","DOI":"10.3389\/fmed.2021.612506","volume":"8","author":"M Pizzonia","year":"2021","unstructured":"Pizzonia M, Casabella A, Natali M, Petrocchi L, Carmisciano L, Nencioni A, Molfetta L, Giannotti C, Bianchi G, Giusti A, Santolini F, Monacelli F (2021) Osteosarcopenia in very old age adults after hip fracture: a real-world therapeutic standpoint. Front Med (Lausanne) 8:612506","journal-title":"Front Med (Lausanne)"},{"key":"6470_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/jbmr.3972","volume":"35","author":"P Chotiyarnwong","year":"2020","unstructured":"Chotiyarnwong P, McCloskey E, Eastell R, McClung MR, Gielen E, Gostage J, McDermott M, Chines A, Huang S, Cummings SR (2020) A pooled analysis of fall incidence from placebo-controlled trials of denosumab. J Bone Miner Res 35:1014\u20131021","journal-title":"J Bone Miner Res"},{"key":"6470_CR27","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1210\/jc.2014-1742","volume":"99","author":"C Beaudart","year":"2014","unstructured":"Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, Petermans J, Reginster JY, Bruyere O (2014) The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 99:4336\u20134345","journal-title":"J Clin Endocrinol Metab"},{"key":"6470_CR28","doi-asserted-by":"publisher","first-page":"e0215826","DOI":"10.1371\/journal.pone.0215826","volume":"14","author":"L Zhang","year":"2019","unstructured":"Zhang L, Quan M, Cao ZB (2019) Effect of vitamin D supplementation on upper and lower limb muscle strength and muscle power in athletes: a meta-analysis. PLoS ONE 14:e0215826","journal-title":"PLoS ONE"},{"key":"6470_CR29","doi-asserted-by":"publisher","first-page":"116245","DOI":"10.1016\/j.bone.2021.116245","volume":"154","author":"T Trivedi","year":"2022","unstructured":"Trivedi T, Guise TA (2022) Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition. Bone 154:116245","journal-title":"Bone"},{"key":"6470_CR30","doi-asserted-by":"publisher","unstructured":"Kirk B, Lieu N, Vogrin S, Sales M, Pasco JA, Duque G (2022) Serum levels of C-terminal telopeptide (CTX) are associated with muscle function in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glac008","DOI":"10.1093\/gerona\/glac008"},{"key":"6470_CR31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00108-017-0311-3","volume":"58","author":"C Kasperk","year":"2017","unstructured":"Kasperk C (2017) Hypercalcemic crisis and hypocalcemic tetany. Internist (Berl) 58:1029\u20131036","journal-title":"Internist (Berl)"},{"key":"6470_CR32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00402-012-1617-1","volume":"132","author":"C Bartl","year":"2012","unstructured":"Bartl C, Imhoff A, Bartl R (2012) Treatment of bone marrow edema syndrome with intravenous ibandronate. Arch Orthop Trauma Surg 132:1781\u20131788","journal-title":"Arch Orthop Trauma Surg"},{"key":"6470_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/jbmr.4493","volume":"37","author":"L Seefried","year":"2022","unstructured":"Seefried L, Genest F, Baumann J, Heidemeier A, Meffert R, Jakob F (2022) Efficacy of zoledronic acid in the treatment of nonmalignant painful bone marrow lesions: a triple-blind, randomized, placebo-controlled phase III clinical trial (ZoMARS). J Bone Miner Res 37:420\u2013427","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06470-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06470-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06470-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T08:08:28Z","timestamp":1665130108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06470-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6470"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06470-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval for this retrospective study was obtained from the local ethics committee. The study reports according to the STROBE guidelines for reporting observational studies. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Tobias Rupp, Emil von Vopelius, Andr\u00e9 Strahl, Florian Barvencik, Michael Amling and Tim Rolvien declare that they have no conflict of interest. Ralf Oheim has served as a speaker and advisory board member for Kyowa Kirin, Inozyme and UCB and has received an institutional research grant from Kyowa Kirin and UCB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}